Though insulin sensitizers (i.e., biguanides [49] and thiazolidinediones [50]) have been shown to slow the progression of pre-diabetes to some extent, these agents have an upper dosage limitation and thus cannot be up titrated when its biological effect weakens. The gene discussed is INS; the disease is diabetes mellitus.